[1]
2025. Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?. Reumatismo. 77, 2 (Jan. 2025). DOI:https://doi.org/10.4081/reumatismo.2025.1754.